| Metric | შპს ფორტრეს ფარმასიუტიკალ თრეიდინგ | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾10.6m₾19.5m | ₾2.36bn₾2.11bn |
| Revenue growth | -45.9% | 11.8% |
| Profitability | ||
| EBITDA | ₾817k₾790k | — |
| EBITDA margin | 7.7%4.1% | — |
| Net profit | ₾382k₾790k | ₾1.24bn₾1.12bn |
| Net margin | 3.6%4.1% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾9.1m₾17.3m | ₾37.66bn₾31.77bn |
| Total equity | -₾5.8m₾3.8m | ₾5.45bn₾4.75bn |
| ROE | —21.1% | 22.8%23.6% |